Home LiteratureArticle Details
PMID: 638980 Published · ppublish English Journal Article

Adenocarcinoma of the stomach: review of 1,497 cases.

Cancer ·Vol. 41 ·No. 3 ·1978-03-00 ·Pages 941-7

Dupont JB, Lee JR, Burton GR, Cohn I

Abstract

The records of 1,497 patients with histologically proven adenocarcinoma of the stomach were reviewed from Charity Hospital over the 25-year period, 1948 to 1973. The operability rate was 82% and the resectability rate was 48%. In this series gastric carcinoma predominated in males and Negroes. Necropsy studies indicate a similar frequency of involvement of various organs in patients not operated upon as well as those subjected to a prior operation, which suggests the need for some therapeutic endeavors aimed at a wider base than the primary organ. The five-year survival rate, 7.4 overall, varied from 2.0% after esophagogastrectomy to 22.1% after radical subtotal gastrectomy, and to 30.3% for those with localized disease. One hundred one patients survived five years or more, and 5.4% survived ten years or more after the diagnosis of gastric cancer. Radical subtotal gastrectomy gave the best results in this series, whether measured in terms of median survival, five-year survival, or operative mortality. Esophagogastrectomy and by-pass procedures had high mortality and low survival rates, and should be reserved for special conditions.

MeSH Terms
Adenocarcinoma/mortality,surgery Adult Aged Autopsy Female Gastrectomy/methods Humans Male Middle Aged Postoperative Complications Stomach Neoplasms/mortality,surgery
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Dupont J B
Lee J R
Burton G R
Cohn I
Article Info
Journal
Cancer
Abbr.
Cancer
ISSN
0008-543X
Published
1978-03-00
Pages
941-7
Language
English
Region
United States
NLM ID
0374236
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com